Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial (Q33410172)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial |
scientific article |
Statements
1 reference
Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial (English)
1 reference
Martha Lacy
1 reference
Pieter Sonneveld
1 reference
Philippe Moreau
1 reference
Hartmut Goldschmidt
1 reference
Antonio Palumbo
1 reference
Katja Weisel
1 reference
Laurent Garderet
1 reference
Andrew Belch
1 reference
Michel Delforge
1 reference
Lionel Karlin
1 reference
Anne Banos
1 reference
Adrian Alegre
1 reference
Stephen Schey
1 reference
Lars Sternas
1 reference
Kevin Song
1 reference
Christine Chen
1 reference
Valentina Ivanova
1 reference
Joaquin Martinez-Lopez
1 reference
Xin Yu
1 reference
Christian Jacques
1 reference
Mohamed Zaki
1 reference
3 September 2013
1 reference
1 reference
Identifiers
1 reference